Seminar - Online
The webinar clarifies the regulatory concern that FDA has and whether subjecting Laboratory Developed Tests (LDTs) to FDA's device Quality System Regulation can make a measurable difference in the safety and effectiveness (reliability) of special IVDs. The arguments on both sides of the issue will be identified and how regulation may adversely impact the quality of health care we have today. The presumption by FDA is that regulation will improve these special IVDs and, thereby, improve the quality of health care.
Organization: Compliance Trainings (https://compliancetrainings.com)
For more information, please visit: https://compliancetrainings.
com/SiteEngine/ ProductDetailView.aspx?id= FDB1552
Monday, June 15, 2015 (13:00 - 14:00)
Mississauga, Ontario 44813, Canada
Contact: Compliance Trainings (firstname.lastname@example.org)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.